D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Repligen
RGEN
$7.39B
| $18.3M | 0.02% |
212,970
-51,001
| -19% | -$3.48M |
|
777
PUT
Amgen
AMGN
$203B
| $18.3M | 0.02% |
+99,300
| New | +$17.8M |
|
778
Alkermes
ALKS
$8.79B
| $18.3M | 0.02% |
810,821
+463,063
| +133% | +$12.7M |
|
779
Teradata
TDC
$2.8B
| $18.3M | 0.02% |
509,697
+160,107
| +46% | +$6.24M |
|
780
AutoNation
AN
$7.1B
| $18.2M | 0.02% |
434,058
+15,841
| +4% | +$630K |
|
781
SM Energy
SM
$7.26B
| $18.2M | 0.02% |
1,453,732
+337,996
| +30% | +$4.91M |
|
782
3D Systems Corp
DDD
$430M
| $18.2M | 0.02% |
1,996,537
-601,415
| -23% | -$5.69M |
|
783
CALL
RH
RH
$3.4B
| $18.2M | 0.02% |
157,100
| – | – |
|
784
Boston Scientific
BSX
$67.6B
| $18.2M | 0.02% |
422,523
-227,153
| -35% | -$8.74M |
|
785
CareDx
CDNA
$1.88B
| $18.1M | 0.02% |
503,099
+349,920
| +228% | +$11.2M |
|
786
PUT
American Tower
AMT
$77.7B
| $18.1M | 0.02% |
88,300
+75,400
| +584% | +$15.2M |
|
|
AVTA
787
DELISTED
Avantax, Inc. Common Stock
AVTA
| $18.1M | 0.02% |
594,416
-33,526
| -5% | -$1.1M |
|
788
CALL
Union Pacific
UNP
$178B
| $18M | 0.02% |
106,700
+60,500
| +131% | +$10.4M |
|
|
CIT
789
DELISTED
CIT Group Inc.
CIT
| $18M | 0.02% |
342,630
+180,661
| +112% | +$9.14M |
|
790
Travere Therapeutics
TVTX
$5.27B
| $17.9M | 0.02% |
891,667
+33,078
| +4% | +$653K |
|
791
Estee Lauder
EL
$30.1B
| $17.8M | 0.02% |
97,339
+30,079
| +45% | +$5.14M |
|
792
Boston Beer
SAM
$1.91B
| $17.8M | 0.02% |
47,173
-1,439
| -3% | -$456K |
|
|
SGI
793
Somnigroup International
SGI
$15.3B
| $17.8M | 0.02% |
969,320
-213,048
| -18% | -$3.44M |
|
794
SPS Commerce
SPSC
$2.41B
| $17.8M | 0.02% |
347,530
-138,006
| -28% | -$7.19M |
|
795
Paylocity
PCTY
$6.97B
| $17.8M | 0.02% |
189,233
-41,321
| -18% | -$3.92M |
|
796
Credit Acceptance
CACC
$5.78B
| $17.7M | 0.02% |
36,612
+3,006
| +9% | +$1.43M |
|
797
SLM Corp
SLM
$4.78B
| $17.7M | 0.02% |
1,821,654
+839,576
| +85% | +$8.32M |
|
798
Equinor
EQNR
$91.4B
| $17.7M | 0.02% |
+894,840
| New | +$18.9M |
|
799
CALL
Five Below
FIVE
$11.5B
| $17.7M | 0.02% |
147,300
+22,300
| +18% | +$2.93M |
|
800
PUT
Humana
HUM
$45.8B
| $17.7M | 0.02% |
66,600
+16,600
| +33% | +$4.21M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.